SCHEMBL31035752

SCHEMBL31035752

CCCCCCCC(=O)OCCC(CCCCC)CCC(CCC(CCCCC)CCS[C@@H]1CCCC[C@H]1OC(=O)CCCCCCC)N(C)CCCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27299268 0.84 NAAA (0.34) —
SCHEMBL27303835 0.84 NAAA (0.34) —
SCHEMBL27303854 0.78 — —
SCHEMBL27299269 0.78 — —
SCHEMBL30837981 0.75 TLR2 (0.32) —
SCHEMBL27300108 0.75 NAAA (0.41) —
SCHEMBL30842641 0.74 TLR2 (0.40) —
SCHEMBL30837935 0.73 TLR2 (0.37) —
SCHEMBL30837988 0.73 TLR2 (0.37) —
SCHEMBL30837984 0.73 TLR2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240398977-A1 SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-12-05 — — US disclosed
US-12121591-B2 Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents NANOVATION THERAPEUTICS INC. (CA) 2024-10-22 — — US disclosed
US-20240261430-A1 SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-08-08 — — US disclosed
Send feedback